“Application of Nanocarrier-Based Targeted Drug Delivery in the Treatment of Liver Fibrosis and Vascular Diseases” (2025) Journal of Medicine and Life Sciences, 1(2), pp. 63–69. doi:10.71222/bc9c9s73.